chr11-94458937-T-G
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_005591.4(MRE11):c.1500+471A>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.312 in 152,010 control chromosomes in the GnomAD database, including 7,791 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.31 ( 7791 hom., cov: 32)
Consequence
MRE11
NM_005591.4 intron
NM_005591.4 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.262
Publications
13 publications found
Genes affected
MRE11 (HGNC:7230): (MRE11 homolog, double strand break repair nuclease) This gene encodes a nuclear protein involved in homologous recombination, telomere length maintenance, and DNA double-strand break repair. By itself, the protein has 3' to 5' exonuclease activity and endonuclease activity. The protein forms a complex with the RAD50 homolog; this complex is required for nonhomologous joining of DNA ends and possesses increased single-stranded DNA endonuclease and 3' to 5' exonuclease activities. In conjunction with a DNA ligase, this protein promotes the joining of noncomplementary ends in vitro using short homologies near the ends of the DNA fragments. This gene has a pseudogene on chromosome 3. Alternative splicing of this gene results in two transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
MRE11 Gene-Disease associations (from GenCC):
- ataxia-telangiectasia-like disorder 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- prostate cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.85).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.387 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MRE11 | NM_005591.4 | c.1500+471A>C | intron_variant | Intron 13 of 19 | ENST00000323929.8 | NP_005582.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MRE11 | ENST00000323929.8 | c.1500+471A>C | intron_variant | Intron 13 of 19 | 1 | NM_005591.4 | ENSP00000325863.4 | |||
MRE11 | ENST00000323977.7 | c.1500+471A>C | intron_variant | Intron 13 of 18 | 1 | ENSP00000326094.3 | ||||
MRE11 | ENST00000407439.7 | c.1509+471A>C | intron_variant | Intron 13 of 19 | 2 | ENSP00000385614.3 | ||||
MRE11 | ENST00000393241.8 | c.1500+471A>C | intron_variant | Intron 13 of 19 | 5 | ENSP00000376933.4 |
Frequencies
GnomAD3 genomes AF: 0.312 AC: 47422AN: 151892Hom.: 7789 Cov.: 32 show subpopulations
GnomAD3 genomes
AF:
AC:
47422
AN:
151892
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.312 AC: 47438AN: 152010Hom.: 7791 Cov.: 32 AF XY: 0.318 AC XY: 23616AN XY: 74292 show subpopulations
GnomAD4 genome
AF:
AC:
47438
AN:
152010
Hom.:
Cov.:
32
AF XY:
AC XY:
23616
AN XY:
74292
show subpopulations
African (AFR)
AF:
AC:
8622
AN:
41488
American (AMR)
AF:
AC:
6035
AN:
15264
Ashkenazi Jewish (ASJ)
AF:
AC:
1155
AN:
3472
East Asian (EAS)
AF:
AC:
2027
AN:
5168
South Asian (SAS)
AF:
AC:
1844
AN:
4822
European-Finnish (FIN)
AF:
AC:
4217
AN:
10540
Middle Eastern (MID)
AF:
AC:
120
AN:
292
European-Non Finnish (NFE)
AF:
AC:
22531
AN:
67938
Other (OTH)
AF:
AC:
693
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
1652
3304
4957
6609
8261
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
482
964
1446
1928
2410
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
1210
AN:
3458
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.